← Eichor
Study identifier: NCT06651879 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ultrasound Airway Assessment of Critically Ill Preeclamptic; Comparison Between Two Technique

Condition: Critical Illness · Difficult; Intubation, Postpartum, During Puerperium · Pre-Eclampsia  ·  Sponsor: Ain Shams University

PhaseNA
Planned participants50
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

Unexpected difficult airway exposes the patient to serious morbidity and even mortality. The changes in pregnancy and preeclampsia increase the risk of difficult intubation. Proper anticipation affects the outcome and enhances safety, especially in critically ill patients. This research aims to assess the superiority of either 2 views or 5 views ultrasound assessment in predictivity of difficult airway (difficult ventilation, laryngoscopy, and intubation) and their comparison to traditional clinical examination by El-Ganzouri Risk Index (EGRI) in critically ill obstetric patients with pre-eclampsia.

This description comes directly from the study's public registry record.

Talk to the study team

wessam selima, MD  ·  01001958858  ·  w.z.selima@gmail.com

ahmed moustafa, MD  ·  01121318459  ·  drahmed.mostafa.mohamed@med.asu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Ain shams universityCairo, Cairo Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06651879